Literature DB >> 19009526

Resident enteric microbiota and CD8+ T cells shape the abundance of marginal zone B cells.

Bo Wei1, Thomas T Su, Harnisha Dalwadi, Robert P Stephan, Daisuke Fujiwara, Tiffany T Huang, Sarah Brewer, Lindy Chen, Moshe Arditi, James Borneman, David J Rawlings, Jonathan Braun.   

Abstract

Since enteric microbial composition is a distinctive and stable individual trait, microbial heterogeneity may confer lifelong, non-genetic differences between individuals. Here we report that C57BL/6 mice bearing restricted flora microbiota, a distinct but diverse resident enteric microbial community, are numerically and functionally deficient in marginal zone (MZ) B cells. Surprisingly, MZ B-cell levels are minimally affected by germ-free conditions or null mutations of various TLR signaling molecules. In contrast, MZ B-cell depletion is exquisitely dependent on cytolytic CD8(+) T cells, and includes targeting of a cross-reactive microbial/endogenous MHC class 1B antigen. Thus, members of certain enteric microbial communities link with CD8(+) T cells as a previously unappreciated mechanism that shapes innate immunity dependent on innate-like B cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19009526      PMCID: PMC2734463          DOI: 10.1002/eji.200838432

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  63 in total

Review 1.  B-1 cells and the intestinal microflora.

Authors:  N A Bos; J J Cebra; F G Kroese
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk.

Authors:  F Martin; J F Kearney
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

3.  CXCL13 is required for B1 cell homing, natural antibody production, and body cavity immunity.

Authors:  K Mark Ansel; Ruth B S Harris; Jason G Cyster
Journal:  Immunity       Date:  2002-01       Impact factor: 31.745

Review 4.  Autoreactivity by design: innate B and T lymphocytes.

Authors:  A Bendelac; M Bonneville; J F Kearney
Journal:  Nat Rev Immunol       Date:  2001-12       Impact factor: 53.106

Review 5.  How the immune system works to protect the host from infection: a personal view.

Authors:  C A Janeway
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

6.  Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens.

Authors:  F Martin; A M Oliver; J F Kearney
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

Review 7.  Marginal-zone B cells.

Authors:  Flavius Martin; John F Kearney
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

8.  The Crohn's disease-associated bacterial protein I2 is a novel enteric t cell superantigen.

Authors:  H Dalwadi; B Wei; M Kronenberg; C L Sutton; J Braun
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

9.  Perforin-independent regulation of dendritic cell homeostasis by CD8(+) T cells in vivo: implications for adaptive immunotherapy.

Authors:  B Ludewig; W V Bonilla; T Dumrese; B Odermatt; R M Zinkernagel; H Hengartner
Journal:  Eur J Immunol       Date:  2001-06       Impact factor: 5.532

10.  Transitional B lymphocyte subsets operate as distinct checkpoints in murine splenic B cell development.

Authors:  Thomas T Su; David J Rawlings
Journal:  J Immunol       Date:  2002-03-01       Impact factor: 5.422

View more
  27 in total

1.  Cutting edge: regulation of TLR4-driven B cell proliferation by RP105 is not B cell autonomous.

Authors:  Jessica L Allen; Leah M Flick; Senad Divanovic; Shaun W Jackson; Richard Bram; David J Rawlings; Fred D Finkelman; Christopher L Karp
Journal:  J Immunol       Date:  2012-01-30       Impact factor: 5.422

Review 2.  Intestinal microbiome and lymphoma development.

Authors:  Mitsuko L Yamamoto; Robert H Schiestl
Journal:  Cancer J       Date:  2014 May-Jun       Impact factor: 3.360

Review 3.  Toll-like receptors--sentries in the B-cell response.

Authors:  Isabelle Bekeredjian-Ding; Gaetan Jego
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

4.  Regulation of humoral immunity by gut microbial products.

Authors:  Myunghoo Kim; Chang H Kim
Journal:  Gut Microbes       Date:  2017-02-28

Review 5.  The thyroid, the eyes and the gut: a possible connection.

Authors:  D Covelli; M Ludgate
Journal:  J Endocrinol Invest       Date:  2017-01-07       Impact factor: 4.256

Review 6.  Gut Microbiome Modulates Response to Cancer Immunotherapy.

Authors:  Md Abdul Wadud Khan; Gabriel Ologun; Reetakshi Arora; Jennifer L McQuade; Jennifer A Wargo
Journal:  Dig Dis Sci       Date:  2020-03       Impact factor: 3.199

7.  Bacteria associated with immunoregulatory cells in mice.

Authors:  Laura L Presley; Bo Wei; Jonathan Braun; James Borneman
Journal:  Appl Environ Microbiol       Date:  2009-12-11       Impact factor: 4.792

8.  Constitutively CD40-activated B cells regulate CD8 T cell inflammatory response by IL-10 induction.

Authors:  Pandelakis A Koni; Anna Bolduc; Mayuko Takezaki; Yutetsu Ametani; Lei Huang; Jeffrey R Lee; Stephen L Nutt; Masahito Kamanaka; Richard A Flavell; Andrew L Mellor; Takeshi Tsubata; Michiko Shimoda
Journal:  J Immunol       Date:  2013-02-25       Impact factor: 5.422

Review 9.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

10.  Intestinal bacteria modify lymphoma incidence and latency by affecting systemic inflammatory state, oxidative stress, and leukocyte genotoxicity.

Authors:  Mitsuko L Yamamoto; Irene Maier; Angeline Tilly Dang; David Berry; Jared Liu; Paul M Ruegger; Jiue-In Yang; Phillip A Soto; Laura L Presley; Ramune Reliene; Aya M Westbrook; Bo Wei; Alexander Loy; Christopher Chang; Jonathan Braun; James Borneman; Robert H Schiestl
Journal:  Cancer Res       Date:  2013-07-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.